blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2640392

EP2640392 - SUBSTITUTED 4-(SELENOPHEN-2(OR 3)-YLAMINO)PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.11.2015
Database last updated on 05.10.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Kasina Laila Innova Pharmaceuticals Private Ltd.
40-15-14 Brindavan Colony Labbipet Vijayawada 520 010
Andhra Pradesh / IN
[2013/39]
Inventor(s)01 / GOKARAJU, Ganga Raju
40-15-14 Brindavan Colony
Labbipet
Vijayawada 520010 Andhra Pradesh / IN
02 / KASINA, Sudhakar
8215 E. Mercer Way
Mercer Island, WA 98040 / US
03 / SOMEPALLI, Venkateswarlu
40-15-14 Brindavan Colony
Labbipet
Vijayawada 520010 Andhra Pradesh / IN
04 / GOKARAJU, Rama Raju
40-15-14 Brindavan Colony
Labbipet
Vijayawada 520010 Andhra Pradesh / IN
05 / GOKARAJU, Venkata Kanaka Ranga Raju
40-15-14 Brindavan Colony
Labbipet
Vijayawada 520 010 Andhra Pradesh / IN
06 / BHUPATHIRAJU, Kiran
40-15-14 Brindavan Colony
Labbipet
Vijayawada 520 010 Andhra Pradesh / IN
07 / GOLAKOTI, Trimurtulu
40-15-14 Brindavan Colony
Labbipet
Vijayawada 520 010 Andhra Pradesh / IN
08 / SENGUPTA, Krishanu
40-15-14 Brindavan Colony
Labbipet
Vijayawada 520 010 Andhra Pradesh / IN
09 / ALLURI, Venkata Krishna Raju
40-15-14 Brindavan Colony
Labbipet
Vijayawada 520 010 Andhra Pradesh / IN
 [2013/39]
Representative(s)Isarpatent
Patent- und Rechtsanwälte Barth
Charles Hassa Peckmann & Partner mbB
Postfach 44 01 51
80750 München / DE
[N/P]
Former [2013/39]Isarpatent
Patent- und Rechtsanwälte
Postfach 44 01 51
80750 München / DE
Application number, filing date11841996.917.11.2011
WO2011IN00801
Priority number, dateIN2010CHE346818.11.2010         Original published format: IN CH34682010
[2013/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012066578
Date:24.05.2012
Language:EN
[2012/21]
Type: A2 Application without search report 
No.:EP2640392
Date:25.09.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 24.05.2012 takes the place of the publication of the European patent application.
[2013/39]
Type: B1 Patent specification 
No.:EP2640392
Date:07.01.2015
Language:EN
[2015/02]
Search report(s)International search report - published on:US19.07.2012
(Supplementary) European search report - dispatched on:EP11.02.2014
ClassificationIPC:A61K31/517, C07D471/04, C07D487/04, C07D491/048, C07D421/12, C07D495/04, C07D517/04, C07D513/04, A61K31/519, A61P35/00, A61K45/06, A61K31/5377
[2014/11]
CPC:
C07D421/12 (EP,KR,US); A61K31/506 (KR); A61K31/517 (US);
A61K31/519 (US); A61K31/5377 (US); A61K45/06 (US);
A61P13/08 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P17/02 (EP); A61P17/06 (EP); A61P19/08 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P9/00 (EP);
A61P9/12 (EP); C07D471/04 (EP,US); C07D487/04 (EP,US);
C07D491/048 (EP,US); C07D495/04 (EP,US); C07D513/04 (EP,US);
C07D517/04 (EP,US) (-)
Former IPC [2013/39]A61K31/517
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/39]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:SUBSTITUIERTE 4-(SELENOPHEN-2-(ODER 3-)YLAMINO-)PYRIMIDINVERBINDUNGEN UND ANWENDUNGSVERFAHREN DAFÜR[2013/39]
English:SUBSTITUTED 4-(SELENOPHEN-2(OR 3)-YLAMINO)PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF[2013/39]
French:COMPOSÉS 4-(SÉLÉNOPHÈN-2(OU 3)-YLAMINO)PYRIMIDINES SUBSTITUÉS ET LEURS PROCÉDÉS D'UTILISATION[2013/39]
Entry into regional phase26.04.2013National basic fee paid 
26.04.2013Search fee paid 
26.04.2013Designation fee(s) paid 
26.04.2013Examination fee paid 
Examination procedure26.04.2013Examination requested  [2013/39]
03.04.2014Amendment by applicant (claims and/or description)
14.08.2014Communication of intention to grant the patent
03.11.2014Fee for grant paid
03.11.2014Fee for publishing/printing paid
03.11.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.08.2014
Opposition(s)08.10.2015No opposition filed within time limit [2015/51]
Fees paidRenewal fee
29.11.2013Renewal fee patent year 03
28.11.2014Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.11.2011
AL07.01.2015
AT07.01.2015
BE07.01.2015
CY07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
MK07.01.2015
MT07.01.2015
NL07.01.2015
PL07.01.2015
PT07.01.2015
RO07.01.2015
RS07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
SM07.01.2015
TR07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
[2018/46]
Former [2018/31]HU17.11.2011
AT07.01.2015
BE07.01.2015
CY07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
MK07.01.2015
MT07.01.2015
NL07.01.2015
PL07.01.2015
PT07.01.2015
RO07.01.2015
RS07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
SM07.01.2015
TR07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2017/39]HU17.11.2011
AT07.01.2015
BE07.01.2015
CY07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
MT07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
RS07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
SM07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2016/28]AT07.01.2015
BE07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
RS07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2016/24]AT07.01.2015
BE07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
RS07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2016/12]AT07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
RS07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2016/03]AT07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
RS07.01.2015
SE07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2015/49]AT07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
LV07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
RS07.01.2015
SE07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2015/39]AT07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
LV07.01.2015
NL07.01.2015
PL07.01.2015
RS07.01.2015
SE07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2015/38]AT07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
PL07.01.2015
SE07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2015/37]ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
PL07.01.2015
SE07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
Former [2015/36]ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
SE07.01.2015
BG07.04.2015
NO07.04.2015
Former [2015/35]ES07.01.2015
LT07.01.2015
NO07.04.2015
Former [2015/33]ES07.01.2015
Documents cited:Search[A]US6919338  (MORTLOCK ANDREW [GB], et al) [A] 1-15 * compounds of the examples; column 1, paragraph 2; claims 1,10-12 *;
 [A]WO2008070176  (KUO SHENG-CHU, et al) [A] 1-15 * page 1, paragraph 1; example 7; claims 1,20 *;
 [A]WO2009085040  (DCB USA LLC [US], et al) [A] 1-15* compounds 1-57 on pages 5-10; page 1, paragraph 2; claims 1,24,25 *;
 [A]US2010272678  (GOKARAJU GANGA RAJU [IN], et al) [A] 1-15 * compounds of the examples; page 1, paragraphs 1-5; claims 1,4,7,8,22,23 *
International search[A]US6620804  (CHANG CHING-JER [US], et al);
 [A]US6919338  (MORTLOCK ANDREW [GB], et al);
 [A]US2008021031  (SHIA KAK-SHAN [TW], et al);
 [A]US7417055  (CANNIZZARO CARINA [US], et al);
 [A]US2010272678  (GOKARAJU GANGA RAJU [IN], et al)
by applicantWO2008070176
 WO2009085040
 US2010272678
    - K.M. AUMANN ET AL., ORG. BIOMOL. CHEM., (2007), vol. 5, pages 1276 - 1281
    - AUMANN, K.M., ORG. BIOMOL. CHEM., (2007), vol. 5, pages 1276 - 1281
    - GAZIT, A., BIOORG. MED. CHEM., (1996), vol. 4, pages 1203 - 1207
    - FURUTA, T. ET AL., J MED. CHEM., (2006), vol. 49, pages 2186 - 2192
    - LIU, G., BIOORG. MED. CHEM., (2007), vol. 15, pages 6608 - 6617
    - WANG, J.-Q., BIOORG. MED. CHEM. LETT., (2006), vol. 16, pages 4102 - 4106
    - PLE, P.A., J MED. CHEM., (2004), vol. 47, pages 871 - 887
    - MARZARO, G., TETRAHEDRON, (2010), vol. 66, pages 962 - 968
    - KNESL, P., MOLECULES, (2006), vol. 11, pages 286 - 297
    - SHAUL, M., BIOORG. MED. CHEM., (2004), vol. 12, pages 3421 - 3429
    - FERNANDES, C., BIOORG. MED. CHEM., (2007), vol. 15, pages 3974 - 3980
    - HESSE, S., SYNTHESIS, (2009), pages 1204 - 1208
    - THOMAE, D. ET AL., SYNTHESIS, (2008), pages 1600 - 1606
    - ROBINS, R.K., J AM. CHEM. SOC., (1955), vol. 77, pages 2256 - 2260
    - HORIUCHI, T., BIOORG. MED. CHEM. LETT., (2009), vol. 19, pages 305 - 308
    - FOLEY, L.H., TETRAHEDRON LETT., (1994), vol. 35, pages 5989 - 5992
    - MATSUDA, T., CHEM. PHARM. BULL., (1985), vol. 33, pages 937 - 943
    - FISCHER, R.W., ORG. PROC. RES. DEV., (2001), vol. 5, pages 581 - 586
    - THOMAE, D., TETRAHEDRON, (2008), vol. 64, pages 9309 - 9314
    - LIN, R., BIOORG. MED. CHEM. LETT., (2009), vol. 19, pages 2333 - 2337
    - ZHANG, X., GREEN CHEM., (2009), vol. 11, pages 1881 - 1888
    - WALKER, G., J AM. CHEM. SOC., (1955), vol. 77, pages 6698 - 6699
    - LI, H.-Z., MOLECULES, (2010), vol. 15, pages 9473 - 9485
    - MCKEE, R.L., J AM. CHEM. SOC., (1946), vol. 68, pages 1902 - 1903
    - TSUBONI, S., TETRAHEDRON LETT., (1986), vol. 27, pages 2643 - 2644
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.